{"cord_uid": "otf9ruvj", "sourcedb": "PMC", "sourceid": "PMC5827994", "divid": "29", "text": "ARDS is a multifactorial disease with a heterogeneous pathogenesis and variable timing and clinical presentations . Therefore , one specific therapy is unlikely to improve outcomes . Rather than excluding single therapeutic options , identifying patients ' risk factors and the individual ARDS stage may be more important for successful outcomes . We report here in our retrospective analysis that intravenous IgM administration in the initial stages of severe ARDS did not improve overall outcomes or the severity of disease .", "project": "cdlai_CORD-19", "denotations": []}